EN Official Journal of the European Union C 289/7

Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2004 to 15 November 2004

(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93) (1)

(2004/C 289/07)

Issuing of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93) — Accepted

Date of the decision Name of the medicinal product Holder of the marketing authorisation Number of the entry in the Community Register Date of notification 22.10.2004 EMSELEX Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom EU/1/04/294/001-012 26.10.2004 22.10.2004 Mimpara Amgen Europe BV, Minervum 7061, 4817 ZK Breda, The Netherlands EU/1/04/292/001-012 26.10.2004 22.10.2004 Parareg Amgen Europe BV, Minervum 7061, 4817 ZK Breda, The Netherlands EU/1/04/293/001-012 26.10.2004

Modification of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93) — Accepted

Date of the decision Name of the medicinal product Holder of the marketing authorisation Number of the entry in the Community Register Date of notification 20.10.2004 Zeffix Glaxo Group Ltd, Greenford, Middlesex UB6 0NN, United Kingdom EU/1/99/114/001-003 22.10.2004 20.10.2004 Puregon Organon NV, PO box 20, 5340 BH Oss, The Netherlands EU/1/96/008/038-039 22.10.2004 20.10.2004 Viracept Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom EU/1/97/054/001 EU/1/97/054/003-006 22.10.2004 20.10.2004 Taxotere Aventis Pharma SA, 20 avenue Raymond Aron, F-92165 Antony Cedex, EU/1/95/002/001-002 22.10.2004 20.10.2004 ViraferonPeg Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels EU/1/00/132/001-050 22.10.2004 20.10.2004 PegIntron Schering Plough Europe, Rue de Stalle, 73, B-1180 BrusselsStallestraat, 73, B-1180 Brussel EU/1/00/131/001-050 22.10.2004 22.10.2004 Herceptin Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom EU/1/00/145/001 26.10.2004 22.10.2004 EMEND Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom EU/1/03/262/001-006 26.10.2004 22.10.2004 Sifrol Boehringer Ingelheim International GmbH, Binger Strasse 173 D-55216 Ingelheim am Rhein EU/1/97/050/001-006 EU/1/97/050/009-012 26.10.2004 22.10.2004 Bondronat Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom EU/1/96/012/001-013 26.10.2004 28.10.2004 Agenerase Glaxo Group Ltd, Greenford, Middlesex UB6 0NN, United Kingdom EU/1/00/148/001-004 1.11.2004 28.10.2004 Paxene Norton Healthcare Limited, Albert Basin, Royal Docks, London E16 2QJ, United Kingdom EU/1/99/113/001-004 1.11.2004 28.10.2004 Cancidas Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom EU/1/01/196/001-003 1.11.2004 28.10.2004 Ziagen Glaxo Group Ltd, Greenford, Middlesex UB6 0NN, United Kingdom EU/1/99/112/001-002 1.11.2004 28.10.2004 Ziagen Glaxo Group Ltd, Greenford, Middlesex UB6 0NN, United Kingdom EU/1/99/112/001-002 1.11.2004 28.10.2004 Ytracis CIS bio international, Boite postale 32, F-91192 Gif-sur-Yvette EU/1/03/250/001 3.11.2004 28.10.2004 Mirapexin Boehringer Ingelheim International GmbH, Binder Strasse 173, D-55216 Ingelheim am Rhein EU/1/97/051/001-006 EU/1/97/051/009-012 1.11.2004 28.10.2004 Viraferon Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels Stallestraat, 73, B-1180 Brussel EU/1/99/128/001-008 1.11.2004 28.10.2004 CoAprovel Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, F-75013 Paris EU/1/98/086/001-020 2.11.2004 28.10.2004 Karvezide Bristol-Myers Squibb Pharma EEIG, 141-149 Staines Road, Hounslow TW3 3JA, United Kingdom EU/1/98/085/001-020 1.11.2004 28.10.2004 Viread Gilead Sciences International Limited, Cambridge CB1 6GT United Kingdom EU/1/01/200/001 1.11.2004 28.10.2004 Ammonaps Orphan Europe, Immeuble ‘Le Guillaumet’, F-92046 Paris La Défense EU/1/99/120/001-004 2.11.2004 28.10.2004 IntronA Schering Plough Europe, Rue de Stalle, 73, B-1180 Brussels Stallestraat, 73, B-1180 Brussel EU/1/99/127/001-010 EU/1/99/127/040 2.11.2004 29.10.2004 PEGASYS Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom EU/1/02/221/001-010 5.11.2004 29.10.2004 MabCampath ILEX Pharmaceutical Ltd, 1 & 3 Frederick Sanger Road, The Surrey Research Park, Guildford, Surrey GU2 7YD, United Kingdom EU/1/01/193/002 5.11.2004 29.10.2004 Liprolog Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, The Netherlands EU/1/01/195/001-015 5.11.2004 4.11.2004 Zometa Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom EU/1/01/176/001-006 8.11.2004 4.11.2004 Zyprexa Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, The Netherlands EU/1/96/022/002, EU/1/96/022/004, EU/1/96/022/006, EU/1/96/022/008-012, EU/1/96/022/014, EU/1/96/022/016-022 8.11.2004 4.11.2004 Zyprexa Velotab Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, The Netherlands EU/1/99/125/001-008 8.11.2004 4.11.2004 Zyprexa Velotab Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, The Netherlands EU/1/99/125/001-008 8.11.2004 9.11.2004 Vfend Pfizer Limited, Sandwich, Kent CT13 9NJ, United Kingdom EU/1/02/212/001-026 15.11.2004 12.11.2004 Arixtra Sanofi-Synthelabo 174 avenue de France, F-75013 Paris EU/1/02/206/009-017 16.11.2004 12.11.2004 Quixidar N.V. Organon PO box 20, Kloosterstraat 6, 5340 EB Oss, The Netherlands EU/1/02/207/009-017 16.11.2004

(1) OJ L 214, 24.8.1993, p. 1.